Literature DB >> 11096499

Congenital Valvar Aortic Stenosis.

.   

Abstract

Congenital aortic stenosis is characterized by narrowing of the aortic valve orifice, leading to left ventricular hypertrophy and predisposing the patient to exercise intolerance and myocardial dysfunction. Careful monitoring is essential because of the progressive nature of this lesion. Balloon valvuloplasty is the procedure of choice as intermediate palliation for moderate to severe aortic stenosis. If balloon valvuloplasty is contraindicated, surgical valvotomy has a limited role in initial therapy. If balloon valvuloplasty is unsuccessful or contraindicated because of aortic insufficiency, the Ross operation (removal of the stenotic aortic valve and placement of a pulmonary autograft in the aortic position and a pulmonary homograft in the pulmonary position) is the treatment of choice.

Entities:  

Year:  1999        PMID: 11096499     DOI: 10.1007/s11936-999-0028-2

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  9 in total

1.  Comparison of the aortic homograft and the pulmonary autograft for aortic valve or root replacement in children.

Authors:  G Gerosa; R McKay; J Davies; D N Ross
Journal:  J Thorac Cardiovasc Surg       Date:  1991-07       Impact factor: 5.209

2.  Transvascular balloon dilation for neonatal critical aortic stenosis: early and midterm results.

Authors:  E S Egito; P Moore; J O'Sullivan; S Colan; S B Perry; J E Lock; J F Keane
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

Review 3.  Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Authors:  A S Dajani; K A Taubert; W Wilson; A F Bolger; A Bayer; P Ferrieri; M H Gewitz; S T Shulman; S Nouri; J W Newburger; C Hutto; T J Pallasch; T W Gage; M E Levison; G Peter; G Zuccaro
Journal:  JAMA       Date:  1997-06-11       Impact factor: 56.272

4.  Replacement of aortic and mitral valves with a pulmonary autograft.

Authors:  D N Ross
Journal:  Lancet       Date:  1967-11-04       Impact factor: 79.321

Review 5.  26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease.

Authors:  T P Graham; J T Bricker; F W James; W B Strong
Journal:  J Am Coll Cardiol       Date:  1994-10       Impact factor: 24.094

6.  The pulmonary autograft--a permanent aortic valve.

Authors:  D Ross; M Jackson; J Davies
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191

7.  Usefulness of repeat balloon aortic valvuloplasty in children.

Authors:  D Shim; T R Lloyd; R H Beekman
Journal:  Am J Cardiol       Date:  1997-04-15       Impact factor: 2.778

8.  Critical aortic stenosis in the neonate. A comparison of balloon valvuloplasty and transventricular dilation.

Authors:  R S Mosca; M D Iannettoni; S M Schwartz; A Ludomirsky; R H Beekman; T Lloyd; E L Bove
Journal:  J Thorac Cardiovasc Surg       Date:  1995-01       Impact factor: 5.209

9.  Independent predictors of immediate results of percutaneous balloon aortic valvotomy in children. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators.

Authors:  B W McCrindle
Journal:  Am J Cardiol       Date:  1996-02-01       Impact factor: 2.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.